Arem R, Rokey R, Kiefe C, Escalante D A, Rodriguez A
Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA.
Thyroid. 1996 Oct;6(5):397-402. doi: 10.1089/thy.1996.6.397.
Cardiac atrial and ventricular parameters were determined by Doppler two-dimensional echocardiography at rest and exercise in 8 patients with subclinical hypothyroidism (SCH) (6 women and 2 men; age range: 28-48 years) before and 3 months after achievement of a euthyroid state with incremental adjustment of L-thyroxine therapy. None of the patients had known heart disease. At 3 months of L-thyroxine therapy, TSH levels decreased from 14.8 +/- 9.4 mIU/L to 3.0 +/- 1.5 mIU/L and FTI increased from 7.1 +/- 1.8 to 8.1 +/- 1.9. The cardiac studies were performed at rest, and during incremental exercise load (50, 100, 150 W workload) on a Quinton exercise bicycle. No significant differences were found between the subclinical hypothyroid and euthyroid states in systolic blood pressure at rest (104.8 +/- 12.3 vs 105 +/- 10.1 mm Hg) and exercise (158 +/- 24.9 vs 158.5 +/- 20.9 mm Hg) or diastolic blood pressure at rest (70 +/- 4.7 vs 69 +/- 5.7 mm Hg) and exercise (86 +/- 11.4 vs 89.2 +/- 7.3 mm Hg). All echocardiographic atrial and ventricular parameters were similar before and during L-thyroxine therapy with the exception of a small but significant change in left ventricular diastolic dimension (4.5 +/- 0.3 vs 4.8 +/- 0.4 cm; p < 0.05). All Doppler parameters were not significantly affected by L-thyroxine therapy with the exception of preejection period at stage III exercise (51 +/- 17 vs 39 +/- 13 msec; p < 0.05). Preejection period at other stages of exercise showed trends toward similar differences between subclinical hypothyroidism and euthyroidism, but the differences were not statistically significant. We conclude that the cardiac structure and function overall remains for practical purposes normal in subclinical hypothyroidism. However, the latter may be responsible for a mild prolongation of the preejection period during exercise and a slightly smaller left ventricular diastolic dimension at rest, changes that may not be of clinical significance in patients without underlying heart disease.
在8例亚临床甲状腺功能减退症(SCH)患者(6名女性和2名男性;年龄范围:28 - 48岁)中,通过多普勒二维超声心动图测定了静息和运动时的心脏心房和心室参数,测定时间为通过递增调整左甲状腺素治疗达到甲状腺功能正常状态之前和之后3个月。所有患者均无已知心脏病史。在左甲状腺素治疗3个月时,促甲状腺激素(TSH)水平从14.8±9.4 mIU/L降至3.0±1.5 mIU/L,游离甲状腺素指数(FTI)从7.1±1.8升至8.1±1.9。心脏研究在静息状态下以及在Quinton运动自行车上进行递增运动负荷(50、100、150 W工作量)期间进行。在静息收缩压(104.8±12.3 vs 105±10.1 mmHg)和运动时收缩压(158±24.9 vs 158.5±20.9 mmHg)或静息舒张压(70±4.7 vs 69±5.7 mmHg)和运动时舒张压(86±11.4 vs 89.2±7.3 mmHg)方面,亚临床甲状腺功能减退状态和甲状腺功能正常状态之间未发现显著差异。除左心室舒张内径有小但显著的变化(4.5±0.3 vs 4.8±0.4 cm;p < 0.05)外,左甲状腺素治疗前和治疗期间所有超声心动图心房和心室参数均相似。除运动III期射血前期(5